MONMOUTH JUNCTION, N.J., June 9, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that it was ...
Pall Corp.'s decision to sell some of its blood and transfusion assets, for $550 million, marks a shift in strategy for the global filtration maker during its first year under a new chief executive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results